Kennedy, who has faced opposition from health groups and Democrats, has long sown doubts about the safety and efficacy of ...
NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with a market capitalization of $150 billion and annual revenue exceeding $59 billion, announced today that its Phase 3 BREAKWATER study ...
It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well-being of all.
East Idaho News on MSN6d
Idaho Republican pushes ban of mRNA vaccines against COVID, gene therapy productsA freshman Idaho lawmaker wants to ban most COVID-19 shots for the next decade, with a bill rooted in misconceptions about ...
the technology used in the Moderna and Pfizer shots, the researchers said. In clinical trials, J&J's vaccine had shown an 85% efficacy. In subsequent studies in the general population, this figure ...
1 lineage of Omicron but is already being superseded by sister strain KP.3. Still, Pfizer/BioNTech and Moderna say they expect their new vaccines will retain protective efficacy as the two strains ...
International: Kennedy also gave Cassidy assurances over vaccines, as the 70-year-old environmental lawyer has long sown ...
Robert F. Kennedy, Jr. will begin Senate confirmation hearings on Wednesday as President Donald Trump's pick to lead the ...
WASHINGTON >> Robert F. Kennedy Jr., President Donald Trump’s pick for health secretary, moved closer to securing the job ...
Robert F. Kennedy Jr.'s candidacy for Secretary of Health and Human Services in US President Donald Trump's new administration received a boost on Tuesday when the US Senate Committee on Finance voted ...
The US Senate Finance Committee has advanced President Donald Trump's nomination of Robert F Kennedy Jr as health secretary.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback